Dr. Michael Sherman is chief medical officer and senior vice president for health services at Harvard Pilgrim Health Care, a leading not-for-profit health plan insuring 1.2 million members in Massachusetts, New Hampshire, Maine, and Connecticut. Widely recognized as a pioneer in the development of outcomes-based payment agreements for pharmaceutical and diagnostics, Dr. Sherman is credited with cementing Harvard Pilgrim’s position as a leader among insurers in crafting agreements with pharmaceutical companies that tie payments for a drug to its performance. In 2018, he received Xconomy’s “Contrarian Award” for his contributions, which include having signed the nation’s first such payment model for a gene therapy, helping pave the way for the development of innovative financing models.
Since joining Harvard Pilgrim in 2011, Dr. Sherman has focused the organization on introducing innovative outcomes-based reimbursement models that more effectively engage providers, pharmaceutical companies, and diagnostics companies. In addition to provider engagement strategy and pharmacy management, he is also responsible for medical trend management, clinical policy and utilization management, disease and care management services, quality, and wellness offerings.